SageView Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$6.03M Sell
29,130
-1,034
-3% -$204K 0.2% 62
2025
Q3
$5.59M Buy
30,164
+8,453
+39% +$1.45M 0.19% 68
2025
Q2
$3.61M Buy
21,711
+205
+1% +$31.5K 0.14% 89
2025
Q1
$3.57M Buy
21,506
+4,061
+23% +$635K 0.15% 77
2024
Q4
$2.52M Buy
17,445
+6,778
+64% +$1.05M 0.11% 105
2024
Q3
$1.73M Sell
10,667
-7,132
-40% -$1.14M 0.09% 128
2024
Q2
$2.6M Buy
+17,799
New +$2.65M 0.12% 104
2024
Q1
Sell
-19,359
Closed -$3.07M 639
2023
Q4
$3.07M Buy
19,359
+9,597
+98% +$1.47M 0.13% 97
2023
Q3
$1.52M Sell
9,762
-196
-2% -$32.3K 0.09% 140
2023
Q2
$1.65M Buy
9,958
+880
+10% +$142K 0.09% 139
2023
Q1
$1.41M Buy
9,078
+509
+6% +$82.2K 0.09% 154
2022
Q4
$1.51M Buy
+8,569
New +$1.48M 0.12% 118

Other funds holding JNJ

SageView Advisory Group's JNJ Position: Q4 2025 in Review

SageView Advisory Group reduced its Johnson & Johnson (JNJ) stake by 3.4% in Q4 2025, selling an estimated $204K and leaving 29,130 shares worth $6.03M. The position accounts for 0.2% of the portfolio, ranked #62.

SageView Advisory Group first reported a position in JNJ in Q4 2022 and has held it in 12 quarters since. 4,521 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • SageView Advisory Group held 29,130 shares of Johnson & Johnson worth $6.03M as of Q4 2025.
  • SageView Advisory Group sold 1,034 Johnson & Johnson shares in Q4 2025, an estimated $204K.
  • Johnson & Johnson made up 0.2% of SageView Advisory Group's portfolio in Q4 2025, its #62 holding.
  • SageView Advisory Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 12 quarters since.
  • 4,521 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.